University of Michigan, Ann Arbor, MI, USA.
Sahlgrenska University Hospital, Gothenburg, Sweden.
Adv Ther. 2024 Nov;41(11):3977-3981. doi: 10.1007/s12325-024-02982-y. Epub 2024 Sep 9.
This article summarises key themes from a symposium held during the recent European Respiratory Society congress, which took place in Vienna, Austria, 7-11 September 2024. The symposium was sponsored by GSK and entitled 'Striving for disease stability in COPD: Giving patients more of their best days'. During the session, the speakers (MeiLan Han, Lowie Vanfleteren and Dave Singh) highlighted the specific challenges of chronic obstructive pulmonary disease (COPD), such as its unpredictable and unstable nature, with additional insights provided from patients with COPD in the form of video interviews. The faculty discussed whether treatment standards and goals should be more ambitious to provide all patients the stability and predictability they deserve and the opportunity to do more while living with COPD.
本文总结了于 2024 年 9 月 7 日至 11 日在奥地利维也纳举行的欧洲呼吸学会大会期间举办的一次研讨会的主要内容。该研讨会由葛兰素史克公司赞助，主题为“努力实现 COPD 患者的疾病稳定：让患者拥有更多美好时光”。在会议期间，演讲者（韩美兰、Lowie Vanfleteren 和 Dave Singh）强调了慢性阻塞性肺疾病（COPD）的具体挑战，如该病具有不可预测和不稳定的特点，同时还通过 COPD 患者的视频采访提供了额外的见解。演讲者们讨论了治疗标准和目标是否应该更加雄心勃勃，为所有患者提供他们应得的稳定性和可预测性，以及让他们在患有 COPD 的同时有更多机会参与日常活动的机会。
